Please provide your email address to receive an email when new articles are posted on . Out of 323 drugs, only 10% completed testing in children before receiving FDA approval. Rare disease ...
On May 17, the U.S. Food & Drug Administration (“FDA”) issued two important draft guidance documents, which clarify the agency’s approach to requirements and incentives in the realm of pediatric drug ...
Introduction Pediatric Pharmacology Disasters Testing Drugs in Children Legal and Regulatory Developments: Pediatric Pharmacology in the United States References Legal and Regulatory Developments: ...
The latest research report published by Vantage Market Research, titled "An Increase in Demand and Opportunities for the Global Pediatric Drugs Market 2025-2035," provides a comprehensive analysis of ...
Compassionate use can be the best option for patients who seek treatment and cannot participate in a clinical trial and who have no satisfactory therapeutic alternatives. Pediatric oncologists should ...